TY - JOUR
T1 - The ethics of the Global Kidney Exchange programme
AU - Minerva, Francesca
AU - Savulescu, Julian
AU - Singer, Peter
N1 - Publisher Copyright:
© 2019 Elsevier Ltd
PY - 2019/11/9
Y1 - 2019/11/9
N2 - The Global Kidney Exchange (GKE) programme seeks to facilitate kidney transplants by matching donor–recipient pairs across high-income, medium-income, and low-income countries. The GKE programme pays the medical expenses of people in medium-income and low-income countries, thus enabling them to receive a kidney transplantation they otherwise could not afford. In doing so, the programme increases the global donor pool, and so benefits people in high-income countries by improving their chances of finding a donor match. Nevertheless, the GKE has been accused of being a form of organ trafficking, exploiting the poor, and involving coercion and commodification of donors. We refute these claims, arguing that the GKE promotes global justice and reduces the potential for people in need of kidneys in low-income and medium-income countries to be exploited. Misguided objections should not be allowed to prevent the GKE from realising its potential to reduce suffering and save the lives of rich and poor patients alike.
AB - The Global Kidney Exchange (GKE) programme seeks to facilitate kidney transplants by matching donor–recipient pairs across high-income, medium-income, and low-income countries. The GKE programme pays the medical expenses of people in medium-income and low-income countries, thus enabling them to receive a kidney transplantation they otherwise could not afford. In doing so, the programme increases the global donor pool, and so benefits people in high-income countries by improving their chances of finding a donor match. Nevertheless, the GKE has been accused of being a form of organ trafficking, exploiting the poor, and involving coercion and commodification of donors. We refute these claims, arguing that the GKE promotes global justice and reduces the potential for people in need of kidneys in low-income and medium-income countries to be exploited. Misguided objections should not be allowed to prevent the GKE from realising its potential to reduce suffering and save the lives of rich and poor patients alike.
UR - http://www.scopus.com/inward/record.url?scp=85074503847&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074503847&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(19)32474-2
DO - 10.1016/S0140-6736(19)32474-2
M3 - Review article
C2 - 31676108
AN - SCOPUS:85074503847
SN - 0140-6736
VL - 394
SP - 1775
EP - 1778
JO - The Lancet
JF - The Lancet
IS - 10210
ER -